Erector Spinae Plane Blockade in Pediatric Scoliosis Surgery Patients
Launched by STANFORD UNIVERSITY · Nov 5, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method called the erector spinae plane block (ESPB) to help manage pain after spinal surgery for scoliosis in children and teenagers. Scoliosis is a condition where the spine curves abnormally, and surgery is often needed to correct it. The trial aims to see if using the ESPB can provide effective pain relief without the side effects commonly associated with stronger pain medications like opioids. By injecting a local anesthetic near the spine, the hope is to reduce pain while minimizing the need for these stronger drugs.
To participate in this study, patients need to be between certain ages and diagnosed with idiopathic scoliosis, meaning the cause of their scoliosis is unknown. They will be undergoing a specific type of surgery called single-stage posterior spinal instrumentation and fusion. However, there are some exclusions, such as those with certain medical conditions or those who have had prior surgeries related to their scoliosis. Participants can expect to be monitored closely during the trial, and their pain management plan will be evaluated to see how well the new method works. Overall, this research hopes to improve pain control after scoliosis surgery, making recovery easier for young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA I-III
- • Diagnosed with Idiopathic scoliosis
- • Undergoing single-stage posterior spinal instrumentation and fusion
- Exclusion Criteria:
- • Thorascopic tethering procedure
- • Two-stage procedure
- • Abnormal developmental profile
- • Congenital/neuromuscular scoliosis
- • Requiring PICU admission
- • Known allergy to lidocaine
- • Known cardiac, renal or liver disease or dysfunction
- • Pre-existing pain complaints, i.e. on regular analgesic medications
- • Current psychiatric diagnosis, e.g. anxiety, depression, eating disorder, defined according to DSM criteria.
- • Requiring non-standard post-op pain management
- • Any history of seizures
- • Unplanned staged procedure
- • Weight \< 5th centile or \> 85th centile for age
- • Porphyria
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials